Tesi sul tema "Anti-cancer"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 saggi (tesi di laurea o di dottorato) per l'attività di ricerca sul tema "Anti-cancer".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi le tesi di molte aree scientifiche e compila una bibliografia corretta.
Wheate, Nial Joseph Chemistry Australian Defence Force Academy UNSW. "Platinum anti-cancer complexes". Awarded by:University of New South Wales - Australian Defence Force Academy. School of Chemistry, 2001. http://handle.unsw.edu.au/1959.4/38704.
Testo completoBugarcic, Tijana. "Ruthenium arene anti-cancer complexes". Thesis, University of Edinburgh, 2008. http://hdl.handle.net/1842/13265.
Testo completoKuh, Hyo-Jeong. "Target site pharmacokinetics of anti-AIDS and anti-cancer agents /". The Ohio State University, 1997. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487943341527965.
Testo completoLau, Kelvin Kar Wing. "Vascular targeting of anti-cancer therapy". Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.311869.
Testo completoCao, Siyu. "Designer bacteria as anti-cancer agents". Thesis, Griffith University, 2013. http://hdl.handle.net/10072/366498.
Testo completoThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Lyu, Jun Fang. "Discovery of cholesterol trafficking inhibitors as novel anti-angiogenic and anti-cancer agents". Thesis, University of Macau, 2018. http://umaclib3.umac.mo/record=b3953967.
Testo completoDeng, Zhao. "Anti-microbial and Anti-cancer activity of Traditional Chinese Medicine extracts". Thesis, Griffith University, 2020. http://hdl.handle.net/10072/401446.
Testo completoThesis (Masters)
Master of Science (MSc)
School of Environment and Science
Science, Environment, Engineering and Technology
Full Text
Qi, Ji. "Cane Toad Skin Extracts as Anti-Inflammatory and Anti-Cancer Agents". Thesis, Griffith University, 2016. http://hdl.handle.net/10072/365729.
Testo completoThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Wu, Na. "Identification of anti-resorptive and anti-cancer activities of epigenetic inhibitors". Thesis, University of Oxford, 2017. http://ora.ox.ac.uk/objects/uuid:9ae1e4e5-32b2-40e7-8249-5983d3e1bd6e.
Testo completoTrapika, I. Gusti Made Gde Surya Chandra. "Anti-Cancer Activity of Dendrobium chrysotoxum in human prostate cancer cells". Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22501.
Testo completoLau, Kai Chi. "Quantum chemical studies of anti-cancer complexes /". Zürich : ETH, 2007. http://e-collection.ethbib.ethz.ch/show?type=diss&nr=17547.
Testo completoLam, Fong Ki. "Discovery and evaluation of anti-cancer agents". Thesis, University of Nottingham, 2010. http://eprints.nottingham.ac.uk/11242/.
Testo completoDavison, Zoe. "Transcutaneous delivery of anti-breast cancer agents". Thesis, Cardiff University, 2008. http://orca.cf.ac.uk/54343/.
Testo completoBoys, Sarah K. "Tyrosine derivatives and their anti-cancer applications". Thesis, University of Edinburgh, 2012. http://hdl.handle.net/1842/6243.
Testo completoInman, Martyn William. "Catalytic processes in anti-cancer drug discovery". Thesis, University of Leeds, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493304.
Testo completoDyer, Jolon Matthew. "Diels-Alder approaches to anti-cancer prodrugs". Thesis, University of Canterbury. Chemistry, 1998. http://hdl.handle.net/10092/6781.
Testo completoKärkkäinen, Tiina Sinikka. "Synthesis of glycopeptide-based anti-cancer vaccines". Thesis, University of East Anglia, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.273509.
Testo completoCooper, Margaret S. "Anti-cancer peptides containing modified tyrosine residues". Thesis, University of Nottingham, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.246193.
Testo completoSoldevila, Barreda Joan Josep. "Design of catalytic organometallic anti-cancer drugs". Thesis, University of Warwick, 2014. http://wrap.warwick.ac.uk/63808/.
Testo completoBennett, Ailsa. "Exploiting mitosis to improve anti-cancer strategies". Thesis, University of Manchester, 2017. https://www.research.manchester.ac.uk/portal/en/theses/exploiting-mitosis-to-improve-anticancer-strategies(b29182a1-2f37-47cb-8dc5-cbef76786dd2).html.
Testo completoBire, Christophe. "Données récentes sur la vaccination anti-cancer". Paris 5, 1994. http://www.theses.fr/1994PA05P043.
Testo completoOliva, Francisco. "The Anti-cancer Properties of Podophyllotoxin Analogues". Youngstown State University / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ysu1579197212456721.
Testo completoRichardson, Monica Eilertsen. "Heterocyclic NO-donors as anti-cancer agents". Thesis, Keele University, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.699674.
Testo completoRan, Yingqing. "Applications of liposomes on anti-cancer agents". Diss., The University of Arizona, 2004. http://hdl.handle.net/10150/290047.
Testo completoWong, Suk-yu. "Study of anti-cancer and anti-viral activities of lanthanide and vanadium complexes". View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36584599.
Testo completoWong, Suk-yu, e 黃淑如. "Study of anti-cancer and anti-viral activities of lanthanide and vanadium complexes". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B37674547.
Testo completoMelo, Candice Soares de. "Anti-cancer and anti-malarial 4-aminoquinoline derivatives : synthesis and solid-state investigations". Master's thesis, University of Cape Town, 2006. http://hdl.handle.net/11427/6334.
Testo completoThe work presented in this thesis is two-fold: (i) development of single agents that provide inhibition of both the growth of malaria parasites and of tumour cells in vitro, and (ii) inclusion of these potential novel inhibitors in cyclodextrin host molecules in an attempt to render these dual drugs water-soluble. Of all the current clinically established antimalarials, the 4-aminoquinolines haveproven to be the most significant and efficacious for the treatment and prophylaxis of malaria. However, their efficacy has decreased by the spread of drug resistant strains of the causative agent Plasmodium Jalciparum. Future research into 4-aminoquinoline derivatives as antimalarial agents is still warranted and justified on the basis of several considerations. The quinoline moiety has also been shown to be a substructure in multi-drug resistance reversal agents against certain cancer cell lines and antitumour agents which have demonstrated the ability to act as differentiation-inducing agents. The strategy employed for this project was to hybridize chalcone moieties and their Mannich base derivatives with the 4-aminoquinoline moiety. This dual drug concept uses the basic structure of the chalcone scaffold, which has a wide range of known antimalarial and anticancer activities, and is hybridised with the 4-aminoquinoline moiety, in order to exert maximal biological activity and overcome or prevent drug resistance. Structural variation on the aromatic rings of the chalcone scaffold allowed preliminary structure-activity relationship studies to be undertaken.
Studebaker, Adam Wade. "Targteing uracil exclusion mechanisms for development of anti-viral and anti-cancer therapies". The Ohio State University, 2003. http://rave.ohiolink.edu/etdc/view?acc_num=osu1056034774.
Testo completoStudebaker, Adam W. "Targeting uracil exclusion mechanisms for development of anti-viral and anti-cancer therapies". Connect to this title online, 2003. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1056034774.
Testo completoTitle from first page of PDF file. Document formatted into pages; contains xiii, 210 p.; also includes graphics (some col.). Includes bibliographical references (p. 174-210). Available online via OhioLINK's ETD Center
O'Riley, Hannah Adele. "Mechanisms of the Anti-Metastatic and Cytotoxic Properties of Ruthenium Anti-Cancer Drugs". Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/13881.
Testo completoButler, Gregory James. "Non-steroidal anti-inflammatory drugs and skin cancer /". [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe19122.pdf.
Testo completoBulmer, J. Todd. "Cellular responses to the anti-cancer drug, cisplatin /". *McMaster only, 2001.
Cerca il testo completoZong, Jingyi. "The development of anti-cancer drug delivery systems". Thesis, Durham University, 2016. http://etheses.dur.ac.uk/11927/.
Testo completoOleschuk, Curtis. "Structure-activity studies of bioreductive anti-cancer agents". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0002/MQ32204.pdf.
Testo completoFaragalla, Jane Eliza. "Development of isoflavonoid-derived anti-prostatic cancer agents". Access electronically, 2005. http://www.library.uow.edu.au/adt-NWU/public/adt-NWU20060516.121728/index.html.
Testo completoHill, Richard James. "Immunocompetent tumour model for anti-cancer adenovirus treatment". Thesis, Imperial College London, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414451.
Testo completoHagan, Damien James. "The synthesis of novel anti-cancer acridine derivatives". Thesis, University of Nottingham, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284428.
Testo completoCook, Andrew James. "Metal catalysed approaches to novel anti-cancer agents". Thesis, University of Leeds, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.411359.
Testo completoManoharan, Gunasekar. "Anti-cancer effects of Momordica charantia in-vitro". Thesis, University of Central Lancashire, 2011. http://clok.uclan.ac.uk/2822/.
Testo completoMehta, Shaveta. "Biomarkers of anti-angiogenic therapy in breast cancer". Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:8b3869e3-fd60-450c-b165-0fe773681613.
Testo completoGhandhi, Laura Hester Dena. "Cobalt picolinamide complexes as potential anti-cancer agents". Thesis, University of Leeds, 2017. http://etheses.whiterose.ac.uk/17618/.
Testo completoChuang, Hsiao-Ching. "Mechanistic Validation of Potential Anti-Breast Cancer Therapeutics". The Ohio State University, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=osu1338213365.
Testo completoSindi, Shaimaa Hesham. "Guanidine- Based HDAC-Inhibitors as Anti-Cancer Agents". University of Toledo / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1564676186975875.
Testo completoShahi, Thakuri Pradip. "MODELING ANTI-CANCER DRUG RESISTANCE USING TUMOR SPHEROIDS". University of Akron / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=akron1574725861735168.
Testo completoLaw, Ka Man. "Anti-cancer effect of ginsenosides on nasopharyngeal carcinoma". HKBU Institutional Repository, 2012. https://repository.hkbu.edu.hk/etd_ra/1383.
Testo completoJagdev, Satinder P. K. "Anti-tumour effects of bisphosphonates in breast cancer". Thesis, University of Sheffield, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.427201.
Testo completoBroughton, Laura J. "Characterisation of duramycin as an anti-cancer agent". Thesis, University of Hull, 2016. http://hydra.hull.ac.uk/resources/hull:15303.
Testo completoShehata, Sara <1993>. "Synthesis of Anti-Metastatic Agent for Cancer Theraphy". Master's Degree Thesis, Università Ca' Foscari Venezia, 2018. http://hdl.handle.net/10579/13854.
Testo completoGuardia, Valenzuela Cristina 1990. "Cancer-associated fibroblasts and response to anti-HER2 monoclonal antibodies in breast cancer". Doctoral thesis, Universitat Pompeu Fabra, 2019. http://hdl.handle.net/10803/668327.
Testo completoHER2-positive breast cancer (BC) is an aggressive subtype of this disease. The development of anti-HER2 targeted therapies, particularly the monoclonal antibody (Mab) trastuzumab, significantly improved its otherwise poor prognosis. More recently, another Mab called pertuzumab, has further improved the efficacy of trastuzumab, yet no all patients benefit from the combination of the two Mabs. A proportion of HER2-breast cancer patients will not benefit from anti-HER2 agents, and will ultimately die as a consequence of innate or acquired drug resistance mechanisms. Tumours consist not only of heterogeneous populations of cancer cells, but also of the tumour microenvironment (TME). In recent years, increasing evidence has shown that cancer-associated fibroblasts (CAFs; an abundant stromal cell population within the TME), directly support tumorigenesis and promote therapy resistance. However, at the beginning of this PhD study, there was little published work on the role of CAFs on anti-HER2 targeted therapy resistance. The work presented in this doctoral thesis supported a role of CAFs in tumour resistance to anti-HER2 targeted therapies in HER2+ breast cancer through paracrine secretion of soluble molecules that ultimately will promote breast cancer survival and therapy resistance.
Verghese, Jenson. "Investigations of Novel Mechanisms of Action for Anti-Bacterial and Anti-Cancer Agent Development". VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/611.
Testo completo